Salona Global Medical Device ( (TSE:EVMT) ) has issued an update.
Evome Medical Technologies Inc., a company listed on the TSX Venture Exchange, has announced the granting of 1,000,000 restricted stock units (RSUs) to William Garbarini, who has been appointed as the Chief Operating Officer. These RSUs are part of the company’s 2023 Equity Incentive Plan and will vest over 24 months, with settlement in common shares subject to a hold period as per Canadian securities laws and exchange policies.
More about Salona Global Medical Device
YTD Price Performance: -17.24%
Average Trading Volume: 99,061
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$9.97M
Learn more about EVMT stock on TipRanks’ Stock Analysis page.